Literature DB >> 24365130

Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.

Tammy Quinlan1, Kimberlee A Musser1, Salvatore A Currenti2, Shelley M Zansky2, Tanya A Halse3.   

Abstract

The first report of pertactin-negative variants of Bordetella pertussis in the United States has raised questions about the role of acellular pertussis vaccines in the recent increase of pertussis cases. Our laboratory utilized a sequence-based method to identify mutations in the pertactin gene responsible for these variants and assessed vaccination status from the associated cases. Published by Elsevier Ltd.

Keywords:  Acellular vaccine; Bordetella pertussis; Pertactin-negative variants

Mesh:

Substances:

Year:  2013        PMID: 24365130     DOI: 10.1016/j.mcp.2013.12.003

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  10 in total

1.  Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States.

Authors:  Carlin Aloe; Martin Kulldorff; Barry R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-20       Impact factor: 11.205

2.  Molecular epidemiology of the pertussis epidemic in Washington State in 2012.

Authors:  Katherine E Bowden; Margaret M Williams; Pamela K Cassiday; Andrea Milton; Lucia Pawloski; Marsenia Harrison; Stacey W Martin; Sarah Meyer; Xuan Qin; Chas DeBolt; Azadeh Tasslimi; Nusrat Syed; Ronald Sorrell; Mike Tran; Brian Hiatt; Maria Lucia Tondella
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

Review 3.  Development of improved pertussis vaccine.

Authors:  Martin Rumbo; Daniela Hozbor
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Pertussis outbreak, southeastern Minnesota, 2012.

Authors:  Alexander G Theofiles; Scott A Cunningham; Nicholas Chia; Patricio R Jeraldo; Daniel J Quest; Jayawant N Mandrekar; Robin Patel
Journal:  Mayo Clin Proc       Date:  2014-10       Impact factor: 7.616

5.  Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.

Authors:  M van Gent; C J Heuvelman; H G van der Heide; H O Hallander; A Advani; N Guiso; C H Wirsing von Kőnig; D F Vestrheim; T Dalby; N K Fry; D Pierard; L Detemmerman; J Zavadilova; K Fabianova; C Logan; A Habington; M Byrne; A Lutyńska; E Mosiej; C Pelaz; K Gröndahl-Yli-Hannuksela; A M Barkoff; J Mertsola; A Economopoulou; Q He; F R Mooi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-20       Impact factor: 3.267

6.  Genome Structural Diversity among 31 Bordetella pertussis Isolates from Two Recent U.S. Whooping Cough Statewide Epidemics.

Authors:  Katherine E Bowden; Michael R Weigand; Yanhui Peng; Pamela K Cassiday; Scott Sammons; Kristen Knipe; Lori A Rowe; Vladimir Loparev; Mili Sheth; Keeley Weening; M Lucia Tondella; Margaret M Williams
Journal:  mSphere       Date:  2016-05-11       Impact factor: 4.389

7.  Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.

Authors:  H Bailon; N León-Janampa; C Padilla; D Hozbor
Journal:  BMC Infect Dis       Date:  2016-08-17       Impact factor: 3.090

Review 8.  The Pertussis resurgence: putting together the pieces of the puzzle.

Authors:  Rotem Lapidot; Christopher J Gill
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-12-12

9.  Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.

Authors:  Aldert Zomer; Nao Otsuka; Yukihiro Hiramatsu; Kazunari Kamachi; Naoko Nishimura; Takao Ozaki; Jan Poolman; Jeroen Geurtsen
Journal:  Microb Genom       Date:  2018-05-17

10.  Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.

Authors:  Francisco Carriquiriborde; Victoria Regidor; Pablo M Aispuro; Gabrielli Magali; Erika Bartel; Daniela Bottero; Daniela Hozbor
Journal:  Emerg Infect Dis       Date:  2019-11       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.